Results 2,581-2,600 of 3,998 for speaker:Michael Harty

Select Committee on Health: Message to Dail (28 Mar 2018)

Michael Harty: In accordance with Standing Order 90, the following message will be sent to the Dáil:The Select Committee on Health has considered the following Revised Estimate for public services for the year ending 31 December 2018: Vote 38 - Health. Under Standing Order 89(2), the message is deemed to be the report of the committee.

Written Answers — Department of Health: Medical Products (28 Mar 2018)

Michael Harty: 227. To ask the Minister for Health his plans to examine the issue of accountability, compensation and the provision of medical services in relation to children affected by foetal anti-convulsant syndrome; and if he will make a statement on the matter. [14473/18]

Written Answers — Department of Housing, Planning, and Local Government: Building Regulations (27 Mar 2018)

Michael Harty: 620. To ask the Minister for Housing, Planning, and Local Government his plans for a redress scheme for purchasers of houses and apartments that were not properly constructed and that are non-compliant with building and fire regulations; and if he will make a statement on the matter. [13688/18]

Joint Oireachtas Committee on Health: Scrutiny of EU Legislative Proposals (21 Mar 2018)

Michael Harty: We are now in public session. Is it agreed to further scrutinise COM (2018) 51 on health technology assessment? Agreed. We will suspend for a few moments to allow the witnesses to take their seats.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: This morning we are meeting with representatives from the Irish College of General Practitioners, ICGP, the Royal College of Physicians of Ireland, RCPI, and the Royal College of Surgeons in Ireland, RCSI, to discuss the issue of prescription patterns, the monitoring and auditing of the use of drugs and the effect of trends in prescribing medications. On behalf of the committee, I welcome...

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Professor Fahey. I now call Professor Mary Horgan.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Professor Horgan. Next is the opening statement from the Irish College of General Practitioners, ICGP.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Dr. O'Brien. The attention of this committee was drawn to this issue in recent weeks by media reports suggesting that the medical profession is over-prescribing medication. That is why we have asked the witnesses to attend this morning's meeting. We will take questions from three members at a time. I ask the witnesses to note the questions that are asked and we will come to them...

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank the Senator and I apologise for misnaming Senator Burke earlier.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: We might start with Professor Fahey. If there are other questions, we can pass them down the line.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I call Dr. O'Brien.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: We will now bring in our next contributors, Deputies Durkan and O'Connell.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Deputy Durkan.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: Deputy O'Connell can take up his extra time.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: Does the Deputy have actual questions for the witnesses?

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I wish to comment on generic substitution. Quite often a patient may get 12 different generic substitutions in a year. In other words, he or she goes into a pharmacist and receives a product. On his or her next visit the chemist will suggest that another generic substitute is the same as the last one but it has been produced by a different company. People react to products in different...

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Professor Fahey for his comments and call Professor Horgan.

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: We are here today because there is an expectation that there is a pill for every ill. Patients have an expectation that is a cure for everything. It is very difficult to get that message across. Professor Fahey has a prescription with 14 items on it for a patient who has vitamin and iron deficiencies, probably has atrial fibrillation, has a pancreas deficiency, has chronic obstructive...

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: During the Sláintecare report process, all members of the committee became expert in the inverse care law and Tudor Hart and could lecture on it by the time our deliberations had concluded. We had a very important meeting with Deep End Ireland, which outlined the inverse care law and the deprivation index that should be applied to payments and resources for general practice. Coming...

Joint Oireachtas Committee on Health: Evaluation of the Use of Prescription Drugs: Discussion (21 Mar 2018)

Michael Harty: I thank Professor Tom Fahey of the Royal College of Surgeons, Professor Mary Horgan of the Royal College of Physicians and Dr. Mark Murphy and Dr. John O'Brien from the Irish College of General Practitioners.